Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of key genes and pathways involved in T-DM1-resistance in OE-19 esophageal cancer cells through bioinformatics analysis

1 Sept 2024

Abstract excerpt

Introduction: Esophageal Cancer (EC) ranks among the most common malignancies worldwide. Most EC patients acquire drug resistance to chemotherapy either intrinsically or acquired after T-DM1 treatment, which shows that increasing or decreasing the expression of particular genes might influence chemotherapeutic sensitivity or resistance. Therefore, gaining a deeper understanding of the altered expression of genes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Connective Tissue Growth Factor Research
Share to Glutathione Transferases and Polymorphisms
Share to Inflammatory mediators and NSAID effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39309859
DOI: 10.1016/j.heliyon.2024.e37451

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of key genes and pathways involved in T-DM1-resistance in OE-19 esophageal cancer cells through bioinformatics analysisPMID 39309859Read ↗

Identification of Key Genes and Pathways Governing T-DM1 Resistance in OE-19 Esophageal Cancer Cells through Bioinformatics AnalysisSemantic proximity Read ↗

The involvement of MCTP1 in the drug-resistance of esophageal cancer cellsSemantic proximity Read ↗

Contribution of CMA1 to Esophageal Cancer Immunotherapy and PrognosisSemantic proximity Read ↗

Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancerSemantic proximity Read ↗

Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategySemantic proximity Read ↗

Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinomaSemantic proximity Read ↗

Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patientsSemantic proximity Read ↗

Molecular mechanisms associated with chemoresistance in esophageal cancer.Semantic proximity Read ↗

Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinomaSemantic proximity Read ↗

TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approachSemantic proximity Read ↗

Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression OmnibusSemantic proximity Read ↗

Exploring the hub genes and mechanisms of Daphne altaica. treating esophageal squamous cell carcinoma based on Network Pharmacology and Bioinformatics AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.